Navigation Links
Blood vessels: The pied piper for growing nerve cells
Date:4/10/2008

Researchers at Johns Hopkins have discovered that blood vessels in the head can guide growing facial nerve cells with blood pressure controlling proteins. The findings, which suggest that blood vessels throughout the body might have the same power of persuasion over many nerves, are published this week in Nature.

Were excited to have stumbled across another family of proteins that can tell a growing nerve which way to grow, says David Ginty, Ph.D., a professor of neuroscience at Hopkins and investigator of the Howard Hughes Medical Institute. But the really interesting thing is that the nerves appear to use blood vessels as guideposts to direct their growth in one of several possible directions.

The research team studied in mice a group of about 15,000 nerve cells known as the superior cervical ganglia, or SCG, which extend projections that innervate various structures in the head including the eyes, mouth and salivary glands. The SCG sits in a Y-like branching point of the blood vessel in the neck that supplies the head with blood, the carotid artery. In the developing embryo, nerve projections grow out of the SCG and grow along one of the two branches of the carotid artery; the nerves that grow along the internal carotid innervate the eyes and mouth among other head structures, and those that grow along the external carotid innervate the salivary glands.

To figure out how nerve cells choose to grow along the external carotid artery to innervate the salivary glands, the team looked for genes that appear to be preferentially turned on in the external carotid, and off in the internal carotid. Says Ginty, Theres only two directions they can go and we wanted to know if they choose their direction or if the decision to go one way or the other is random.

They found one gene that is expressed preferentially in the external carotid, a gene that makes the blood pressure regulating protein, endothelin, active. It comes as no surprise that something critical for regulating the cardiovascular system in the adult also is used for directing nerve growth in the developing embryo, says Ginty. The genome is limited and nature has figured out a way to use things over and over again for unrelated functions.

Further examination of the arteries in mouse embryos confirmed that endothelin is found only in the external carotid. To confirm that the nerve cell projections grow toward endothelin, the researchers removed SCGs and grew each one next to an endothelin-soaked bead. Checking on them three days later, the team found that nerves from the SCGs had grown towards the beads. To be certain that endothelin directs nerve growth in the living animal, the researchers then looked in mice that had the endothelin gene removed. Sure enough, these mice had no nerves growing along their external carotid arteries.

The team then wondered if all growing nerves in the SCG can respond to endothelin. So they looked for the endothelin receptors in SCG nerves and found only a subset of SCG nerves make endothelin receptors and concluded that those nerves somehow already had been chosen to respond to the endothelin made by the external carotid.

How do these nerve cells know which target organ theyre supposed to innervate when they all come from the same progenitor? asks Ginty. This is what were going to study next.


'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Cholesterol, blood pressure control may reverse atherosclerosis in adults with diabetes
2. Aggressive Cholesterol, Blood Pressure Treatment Shows Some Benefit
3. Microwave treatments for enlarged prostate cause blood pressure surges
4. Blood pressure enzyme can have tumor-sensing role
5. Stem cell research leads to potential new therapy for rare blood disorder
6. Gator Blood May Be New Source of Antibiotics
7. Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrigs disease
8. Tight Backpack Straps Cut Blood to Shoulders, Arms
9. One-Third of Dementia Cases Laid to Small Blood Vessel Damage
10. Significant dementia risk attributable to small blood vessel damage
11. Lowering Blood Pressure Improves Brain Hemorrhage Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... TSC Advantage has been ... Risk Management Solution Innovations and Security Solution for Government Innovations. Both gold awards ... and its DHS SAFETY Act-designated enterprise security assessment approach. , The ninth annual ...
(Date:8/23/2017)... ... August 23, 2017 , ... The non-profit ... holding an inaugural State of the Science Symposium in partnership with the Global ... 2017. , This symposium provides a forum for global leaders in human nutrition ...
(Date:8/22/2017)... ... August 22, 2017 , ... The Women’s Choice Award, a ... Migraine Relief with the 2017 Women’s Choice Award. The identification by women of an ... out of 4 migraine sufferers are women. In a survey taken by the Women’s ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western ... spoke at a popular international aesthetics conference for medical professionals about the positive ... patients’ health and his growing practice. , Dr. George K. Ibrahim ...
(Date:8/22/2017)... ... August 22, 2017 , ... Each of the past six years, Lightning Labels has sent ... these labels and stickers, demonstrating the variety and creativity of their designs. Submissions this year ... came in. Now, it's time to announce the winners of the sixth annual Photo Contest, ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
Breaking Medicine Technology: